JPS59501459A - カフェインを含んで成る改良された鎮痛及び抗炎症組成物並びにその使用方法 - Google Patents

カフェインを含んで成る改良された鎮痛及び抗炎症組成物並びにその使用方法

Info

Publication number
JPS59501459A
JPS59501459A JP58502643A JP50264383A JPS59501459A JP S59501459 A JPS59501459 A JP S59501459A JP 58502643 A JP58502643 A JP 58502643A JP 50264383 A JP50264383 A JP 50264383A JP S59501459 A JPS59501459 A JP S59501459A
Authority
JP
Japan
Prior art keywords
analgesic
caffeine
pharmaceutical composition
composition according
narcotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58502643A
Other languages
English (en)
Japanese (ja)
Inventor
サンシヤイン・アブラハム
ラスカ・ユ−ジン・エム
シ−ゲル・キヤロル・イ−
Original Assignee
リチヤ−ドソン−ビツクス，インコ−ポレイテイド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by リチヤ−ドソン−ビツクス，インコ−ポレイテイド filed Critical リチヤ−ドソン−ビツクス，インコ−ポレイテイド
Publication of JPS59501459A publication Critical patent/JPS59501459A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
JP58502643A 1982-07-22 1983-07-21 カフェインを含んで成る改良された鎮痛及び抗炎症組成物並びにその使用方法 Pending JPS59501459A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40059782A 1982-07-22 1982-07-22
US400597 1982-07-22

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP6165470A Division JPH07165583A (ja) 1982-07-22 1994-07-18 カフェインを含んで成る改良された鎮痛及び抗炎症組成物並びにその使用方法

Publications (1)

Publication Number Publication Date
JPS59501459A true JPS59501459A (ja) 1984-08-16

Family

ID=23584242

Family Applications (3)

Application Number Title Priority Date Filing Date
JP58502643A Pending JPS59501459A (ja) 1982-07-22 1983-07-21 カフェインを含んで成る改良された鎮痛及び抗炎症組成物並びにその使用方法
JP58502781A Pending JPS59501460A (ja) 1982-07-22 1983-07-21 カフェインを含んで成る改良された鎮痛及び抗炎症組成物並びにその使用方法
JP6165470A Pending JPH07165583A (ja) 1982-07-22 1994-07-18 カフェインを含んで成る改良された鎮痛及び抗炎症組成物並びにその使用方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP58502781A Pending JPS59501460A (ja) 1982-07-22 1983-07-21 カフェインを含んで成る改良された鎮痛及び抗炎症組成物並びにその使用方法
JP6165470A Pending JPH07165583A (ja) 1982-07-22 1994-07-18 カフェインを含んで成る改良された鎮痛及び抗炎症組成物並びにその使用方法

Country Status (15)

Country Link
JP (3) JPS59501459A (it)
AT (2) AT389226B (it)
AU (1) AU558485B2 (it)
BE (1) BE897356A (it)
CA (1) CA1217429A (it)
CH (1) CH659391A5 (it)
DE (1) DE3390116C2 (it)
FR (1) FR2530469A1 (it)
GB (1) GB2134786B (it)
IE (1) IE55367B1 (it)
IT (1) IT1206502B (it)
NL (1) NL191432C (it)
SE (1) SE466481B (it)
WO (1) WO1984000488A1 (it)
ZA (2) ZA835324B (it)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012147986A1 (ja) * 2011-04-28 2012-11-01 興和株式会社 安定な医薬組成物
JP2018076305A (ja) * 2016-10-31 2018-05-17 エスエス製薬株式会社 医薬組成物
JP6811453B1 (ja) * 2020-06-24 2021-01-13 医療法人すぎやま内科 経皮吸収用組成物

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559343A (en) * 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
CH669523A5 (it) * 1986-06-25 1989-03-31 Mepha Ag
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
WO2003004031A1 (en) 2001-07-06 2003-01-16 Endo Pharmaceuticals, Inc. Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
US7914831B2 (en) * 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
JP2006282644A (ja) * 2005-04-05 2006-10-19 Idemitsu Kosan Co Ltd 疲労回復剤
JP2021054728A (ja) * 2019-09-27 2021-04-08 興和株式会社 医薬品

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5423132A (en) * 1977-07-19 1979-02-21 Dai Ichi Seiyaku Co Ltd Analgesic composition
JPS56154416A (en) * 1980-04-30 1981-11-30 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3439094A (en) * 1967-07-20 1969-04-15 Warner Lambert Pharmaceutical Analgesic compositions containing namol xenyrate,caffeine and acetyl-rho-aminophenol
US4049803A (en) * 1976-04-26 1977-09-20 Bristol-Myers Company Augmentation of blood levels of aspirin
JPS54154416A (en) * 1978-05-26 1979-12-05 Tdk Electronics Co Ltd High dielectric constant porcelain composition
US4233315A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233317A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233314A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4234601A (en) * 1978-12-18 1980-11-18 Mcneilab, Inc. Analgesic potentiation
US4233316A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4237140A (en) * 1979-05-18 1980-12-02 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and acetaminophen
US4315936A (en) * 1979-12-17 1982-02-16 Ortho Pharmaceutical Corporation Analgesic composition
US4322427A (en) * 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5423132A (en) * 1977-07-19 1979-02-21 Dai Ichi Seiyaku Co Ltd Analgesic composition
JPS56154416A (en) * 1980-04-30 1981-11-30 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012147986A1 (ja) * 2011-04-28 2012-11-01 興和株式会社 安定な医薬組成物
JPWO2012147986A1 (ja) * 2011-04-28 2014-07-28 興和株式会社 安定な医薬組成物
JP2018076305A (ja) * 2016-10-31 2018-05-17 エスエス製薬株式会社 医薬組成物
JP2022105704A (ja) * 2016-10-31 2022-07-14 エスエス製薬株式会社 医薬組成物
JP6811453B1 (ja) * 2020-06-24 2021-01-13 医療法人すぎやま内科 経皮吸収用組成物
JP2022006361A (ja) * 2020-06-24 2022-01-13 医療法人すぎやま内科 経皮吸収用組成物

Also Published As

Publication number Publication date
BE897356A (fr) 1983-11-14
ATA903983A (de) 1989-04-15
SE8401538L (sv) 1984-03-20
IE55367B1 (en) 1990-08-29
GB2134786A (en) 1984-08-22
FR2530469A1 (fr) 1984-01-27
NL8320240A (nl) 1984-06-01
DE3390116T1 (de) 1985-01-10
IT1206502B (it) 1989-04-27
ZA835326B (en) 1984-09-26
GB8406704D0 (en) 1984-04-18
AU1881683A (en) 1984-02-23
NL191432B (nl) 1995-03-01
GB2134786B (en) 1986-05-08
JPH07165583A (ja) 1995-06-27
AT389226B (de) 1989-11-10
IT8322173A0 (it) 1983-07-21
AU558485B2 (en) 1987-01-29
SE8401538D0 (sv) 1984-03-20
CH659391A5 (de) 1987-01-30
JPS59501460A (ja) 1984-08-16
ATA245988A (de) 1989-08-15
NL191432C (nl) 1995-07-04
IE831715L (en) 1984-01-22
WO1984000488A1 (en) 1984-02-16
ZA835324B (en) 1984-09-26
SE466481B (sv) 1992-02-24
CA1217429A (en) 1987-02-03
AT389998B (de) 1990-02-26
DE3390116C2 (de) 1994-06-16

Similar Documents

Publication Publication Date Title
EP0114886B1 (en) Improved analgesic and anti-inflammatory compositions comprising caffeine
EP0165308B1 (en) Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
AU569935B2 (en) Analgesic & anti-inflammatory compositions containing xanthines
JPS59501459A (ja) カフェインを含んで成る改良された鎮痛及び抗炎症組成物並びにその使用方法
US4464376A (en) Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4656177A (en) Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4777174A (en) Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
SE466889B (sv) Analgetiska och anti-inflammatoriska kompositioner bestaaende av ibuprofen och koffein
US4587249A (en) Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
CA3128321A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
JPH045231A (ja) 慢性痛用鎮痛剤
RU2719376C1 (ru) Лекарственное средство седативного и миорелаксантного действия
CA2624449C (en) Use of neboglamine in the treatment of toxicodependency
JP2003327529A (ja) 鎮咳薬および該鎮咳薬を含有する医薬組成物
Yadav Pharmacology & Toxicology
WO2021063387A1 (zh) 伊马替尼及其衍生物的组合物在制备预防、治疗及防治成瘾复吸药物中的应用
JPH11513386A (ja) β−受容体遮断薬とオピオイドとの新規な組合せ物
JPH0259522A (ja) 悩代謝及び／又は精神症状改善剤